Military veterans suffering from traumatic brain injury may finally have a reason for hope.
A new study from Stanford Medicine finds that a single dose of ibogaine—a psychedelic compound derived from an African shrub—combined with magnesium, can dramatically improve symptoms of PTSD, depression, anxiety, and cognitive dysfunction in veterans with a history of combat-related TBI. Published July 24 in Nature Mental Health, the research offers the strongest evidence yet that ibogaine could help repair invisible wounds left by war.
What Is Ibogaine and Why Now?
Ibogaine is not a new drug. Indigenous communities have used it for centuries in spiritual rituals. In modern times, it’s gained attention for its potential to treat substance use disorders. But in the U.S., ibogaine remains illegal—a Schedule I substance. That hasn’t stopped veterans from seeking treatment abroad, especially in Mexico, where clinics offer ibogaine-assisted therapy legally.
Stanford researchers, led by Dr. Nolan Williams, teamed up with a nonprofit called VETS, Inc. to study 30 former U.S. Special Operations Forces veterans who had independently arranged treatment with ibogaine and magnesium. Nearly all had serious psychiatric symptoms linked to repeated blast exposures. Many had attempted suicide. For some, life had become unrecognizable.
“No other drug has ever been able to alleviate the functional and neuropsychiatric symptoms of traumatic brain injury,” said Williams, an associate professor of psychiatry and behavioral sciences. “The results are dramatic, and we intend to study this compound further.”
Measuring the Before and After
Before treatment, participants underwent extensive psychological and neurological assessments, including brain imaging and EEG monitoring. Then, at a Mexican clinic operated by Ambio Life Sciences, each veteran received oral ibogaine alongside intravenous magnesium to mitigate cardiac risks. Follow-up tests occurred one month later.
The results were striking:
- PTSD symptoms dropped by 88%
- Depression symptoms fell by 87%
- Anxiety symptoms declined by 81%
- Average disability scores fell from 30.2 to just 5.1—effectively eliminating functional disability
- Veterans also showed improved memory, concentration, and executive function
“Before the treatment, I was living life in a blizzard with zero visibility,” said Sean, a 51-year-old Navy veteran. “After ibogaine, the storm lifted.”
What Changed in the Brain?
Ibogaine’s effect on brain waves was measured using high-density EEG. After treatment, veterans showed a shift toward slower theta and alpha brain waves, while faster beta and gamma activity decreased. Researchers believe these changes may reflect enhanced neuroplasticity—the brain’s ability to reorganize and repair itself.
Another finding: cortical activity became less complex after treatment. That’s important, because overactive brain patterns are linked to PTSD and hyperarousal. A reduction in that complexity may indicate a calming of the system.
“This may reflect a transition into a more malleable brain state,” the authors wrote, “allowing some of the marked changes in mental state observed after ibogaine treatment.”
What This Means for PTSD Treatment
Currently, treatments for PTSD and TBI are limited and often fall short. Ibogaine, if approved, could represent a new class of neuro-rehabilitative therapies. Texas has already taken notice, launching a $50 million state-backed initiative to fund ibogaine trials with the goal of seeking FDA approval.
Interestingly, the study also found that brain patterns before treatment could predict who would benefit most. For example, lower pre-treatment alpha wave frequency and complexity were linked to greater improvements in executive function. That opens the door for brain-based screening and personalized psychedelic medicine.
Next Steps and Remaining Questions
Of course, this wasn’t a placebo-controlled trial. And while the veterans reported profound improvements, researchers emphasize the need for randomized, controlled studies to validate the results. Still, the consistency and scale of the improvements make a compelling case for further research.
Ibogaine’s long-lasting effects—some persisting for at least a month—suggest it could do more than just temporarily lift symptoms. It may, researchers speculate, be resetting the brain’s baseline.
A Glimpse of Hope
Craig, a 52-year-old veteran who once forgot his wife’s name due to cognitive decline, said the treatment restored his clarity. “This has resulted in advancement at work and vastly improved my ability to talk to my children and wife.”
For now, ibogaine remains out of reach for most Americans. But this study, and the stories behind it, may push regulators and scientists to look more closely at what the compound can do. For veterans lost in mental fog, it may just help them find their way home.
Journal: Nature Mental Health
DOI: 10.1038/s44220-025-00463-x
ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.
Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.
If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.